Christian Michel Zwaan

24PUBLICATIONS
201CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 27, 2026
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Dec 02, 2025
Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.

Claire Brillac, Dorothée Sémiond, Corina Oprea

|Nov 03, 2025
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.

André Baruchel, Karsten Nysom, Hyoung Jin Kang

|Feb 21, 2025
Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation.

Rick Admiraal, Stefan Nierkens, Marc B Bierings

|Jan 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Leo Mascarenhas, Steven G DuBois, Catherine M Albert

Pageof 4

Frequent Collaborators

4 joint publications

Lucas Moreno

4 joint publications

Karsten Nysom

4 joint publications

Andrew D J Pearson

4 joint publications

Pamela R Kearns